---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-093567"
form_type: "8-K"
ticker: "OSTX"
cik: "0001795091"
company_name: "OS Therapies Inc"
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:02:01.837338+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OS Therapies secures up to $15M equity line from Square Gate Capital over 24 months

## Summary
- Company can sell up to $15M of common stock to Square Gate at 95% of lowest VWAP during valuation period.
- Investor prohibited from short sales or hedging; no warrants issued in the transaction.
- Initial commitment shares equal to 3% of $15M issued as consideration to the investor.
- Proceeds will fund clinical development programs and expand discovery and preclinical activities.
- Registration statement covering resale of shares to be filed with SEC by November 15, 2024.

## SEC filing metadata
- accession: 0001213900-24-093567
- form_type: 8-K
- ticker: OSTX
- cik: 0001795091
- company_name: OS Therapies Inc
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1795091/000121390024093567/0001213900-24-093567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1795091/000121390024093567/ea0219546-8k_osthera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-093567
- JSON: https://secwatch.observer/filing/0001213900-24-093567.json
- Plain text: https://secwatch.observer/filing/0001213900-24-093567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.